|
FAM21C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14089999997602E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.047020E-04 |
| Normal-vs-Stage2 |
3.52080000000088E-05 |
| Normal-vs-Stage3 |
2.26079999999795E-05 |
| Normal-vs-Stage4 |
2.097300E-03 |
| Stage1-vs-Stage2 |
9.950500E-02 |
| Stage1-vs-Stage3 |
4.244800E-01 |
| Stage1-vs-Stage4 |
9.432200E-01 |
| Stage2-vs-Stage3 |
2.922400E-01 |
| Stage2-vs-Stage4 |
1.947180E-01 |
| Stage3-vs-Stage4 |
6.091200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76080000025003E-07 |
| Normal-vs-AfricanAmerican |
2.533000E-01 |
| Normal-vs-Asian |
3.833200E-01 |
| Caucasian-vs-AfricanAmerican |
3.133500E-02 |
| Caucasian-vs-Asian |
1.159550E-04 |
| AfricanAmerican-vs-Asian |
6.160000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.86800000000687E-05 |
| Normal-vs-Female |
1.80140999999079E-05 |
| Male-vs-Female |
8.991800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.007100E-04 |
| Normal-vs-Age(41-60Yrs) |
4.91000000002462E-06 |
| Normal-vs-Age(61-80Yrs) |
3.74690000000122E-05 |
| Normal-vs-Age(81-100Yrs) |
1.387520E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.454010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.597650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.064000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.475000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.771400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.262600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.102400E-02 |
| Classical-VS-Follicular |
8.00499999999982E-05 |
| Classical-VS-Other |
1.423390E-01 |
| Classical-VS-Normal |
5.003500E-04 |
| Tall-VS-Follicular |
4.354200E-01 |
| Tall-VS-Other |
5.641600E-01 |
| Tall-VS-Normal |
5.383800E-04 |
| Follicular-VS-Other |
9.268000E-01 |
| Follicular-VS-Normal |
2.03339999949037E-07 |
| Other-VS-Normal |
1.070100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.72349999996813E-07 |
| Normal-vs-N1 |
2.776700E-03 |
| N0-vs-N1 |
2.837400E-01 |
|
|
